Posts Tagged 'praluent'

Sanofi’s New Injectable Cholesterol Drug Receives FDA Approval

praluent receives FDA approvalSanofi and Regeneron’s new cholesterol drug, Praluent, has received a nod of approval from the U.S. Food and Drug Administration (FDA). Approval comes after the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) found that sufficient evidence existed that the benefits of Praluent outweighed the risks of the drug gave a positive recommendation.

The FDA advisory committee based their recommendation on a study of over 5,000 patients in a double-blind, Phase ...

continue reading...